Ernexa Therapeutics (ERNAW) Net Margin Growth (1y) (2011 - 2024)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Net Margin Growth (1y) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,636.00 |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | 549,991.00 |
| Dec 31, 2020 | -16,361.00 |
| Sep 30, 2020 | -12,911.00 |
| Mar 31, 2020 | -4,440.00 |
| Dec 31, 2019 | -2,592.00 |
| Sep 30, 2019 | -1,136.00 |
| Jun 30, 2019 | 32.00 |
| Mar 31, 2019 | 62.00 |
| Dec 31, 2018 | 1,196.00 |
| Sep 30, 2018 | 724.00 |
| Jun 30, 2018 | 76.00 |
| Mar 31, 2018 | -538.00 |
| Dec 31, 2017 | 1,191.00 |
| Sep 30, 2017 | 699.00 |
| Jun 30, 2017 | 1,276.00 |
| Mar 31, 2017 | 1,727.00 |
| Dec 31, 2016 | 2,921.00 |
| Sep 30, 2016 | 1,165.00 |
| Jun 30, 2016 | 2,667.00 |